The SH3BGR gene has been recently isolated and mapped to chromosome 21 within the Down syndrome (DS) congenital heart disease (CHD) minimal region. As a ®rst step to evaluate the possible involvement of SH3BGR in CHD that affect 40% of DS patients, we have analyzed by in situ hybridization the expression pattern of the mouse homolog gene (Sh3bgr), during development. Our results show that Sh3bgr is already expressed at embryonic day 7.75 (E7.75) in the precardiogenic mesoderm and that from E8.5 to E10.5 its expression is restricted to the heart. In subsequent developmental stages, Sh3bgr transcripts are also detected in skeletal muscle and in some visceral smooth muscles including urinary bladder and gut wall, but not in vascular smooth muscle. Our results, demonstrating that Sh3bgr is expressed in earliest stages of mouse heart development, support a possible role of this gene in heart morphogenesis and, consequently, in the pathogenesis of CHD in DS. q
Results
CHDs are the most common birth defects in humans (Hoffman, 1995) and are present in 40% of the newborns affected by DS, trisomy 21 (Marino et al., 1990) . Such a high incidence suggests that genes mapping to chromosome 21 could be involved in heart morphogenesis and that their abnormal expression in trisomic cells could alter the normal mechanisms of heart development.
Recently we have identi®ed a new gene, named SH3BGR (Scartezzini et al., 1997) , which is expressed in adult heart and skeletal muscle and maps to 21q22.3 within the DS CHD minimal region (Korenberg et al., 1992; Hubert et al., 1997; Hildmann et al., 1999) . The SH3BGR gene encodes for a protein containing a highly conserved SH3 binding motif and a glutamic acid-rich domain at the COOH terminal (Egeo et al., 1998) .
Here we report an expression study of Sh3bgr during mouse development from early embryonic to adult stages, using Northern blotting and in situ hybridization analysis.
Northern blot of mouse adult tissues shows that the expression of Sh3bgr is limited to heart and skeletal muscle, con®rming the expression pattern found in the corresponding human tissues (Fig. 1A) . Northern blot analysis of whole embryos at different stages of development, shows increasing levels of the Sh3bgr transcript, from embryonic day 7 (E7), when a faint signal appears after a week of exposition, to E17 (Fig. 1B) . A single transcript at about 1.3 kb is detected in both adult and embryonic tissues.
Whole mount in situ hybridization was used to examine the expression pattern of Sh3bgr during early stages of embryonic development. As shown in Fig. 2A a positive signal is already detectable at E7.75 in the precardiogenic mesoderm. Therefore, the onset of Sh3bgr expression coincides with that of several genes encoding cardiac transcription factors, including Nkx-2.5 (Harvey, 1996) , GATA-4,-5 and -6 (Laverrie Áre et al., 1994) , MEF2C (Edmonson et al., 1994) and dHAND/eHAND (Srivastava et al., 1995) . From E8.5 to E10.5, namely during the period when the tubular heart undergoes rightward looping, the expression of Sh3bgr is restricted to the developing heart and shows a homogeneous distribution in different heart regions (Fig.  2B±D) . In situ hybridization on tissue sections reveals that Sh3bgr transcripts are present through the embryonic myocardium ( Fig. 3A±E) but not in the cardiac valves nor in the membranous portion of the interventricular septum (Fig. 3 D,E) . The expression persists in the neonatal (Fig. 3L ) and adult heart (not shown). In addition, Sh3bgr transcripts are also detected in developing skeletal and smooth muscle. During skeletal muscle development, transcripts are not present in somites (Fig. 3A,B) . They are ®rst detected at E12.5 in head muscles (not shown) and subsequently also in trunk (Fig. 3C,H ) and limb muscles (Fig. 3I) . The expression of Sh3bgr varies in different smooth muscles. Transcripts are ®rst detected at E12.5 in the muscular wall of the urinary bladder (Fig. 3A,B) , esophagus ( Fig. 3C ) and gut loops (not shown) and is mantained at these sites throughout subsequent developmental stages (Fig. 3F,H) . In contrast, Sh3bgr is not present in other types of smooth muscle, including vascular and bronchial smooth muscle (Fig. 3F,G) . The strong signal seen in pulmonary veins (Fig. 3F,G) is most probably due to the presence of cardiomyocytes in the wall of these vessels (see Kramer and Marks, 1965) , in which transcripts of cardiac contractile proteins are also detectable (see Lyons et al., 1990 ).
Methods

Northern blot
Two commercially available Northern blot ®lters (Clontech), containing poly (A)
1 RNA samples from mouse adult and embryonic tissues were hybridized following the suppliers protocol using a Sh3bgr mouse cDNA as probe. 1 RNA samples (2 mg) from adult mouse tissues: 1, heart; 2, brain; 3, placenta; 4, lung; 5, liver; 6 skeletal muscle; 7, kidney; 8, testis. (B) Northern blot analysis of mouse embryos at different developmental stages. Each lane contains poly (A) 1 RNA (2 mg) from whole embryos at: 1, E7; 2, E11; 3, E15; 4, E17. 
In situ hybridization
In situ hybridization of whole mount embryos was performed as described (Wilkinson, 1992) . A digoxygenin-labeled cRNA probe was synthesized with T7 polymerase from a Sh3bgr mouse cDNA, after digestion with SmaI. In situ hybridization on cryosections was performed according to standard protocols (De Nardi et al., 1993) using cRNA probes labeled with 35 S and autoradiography. 
